ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The German city of Hamburg is establishing European ScreeningPort, a drug discovery service hub designed to provide the missing link in Europe between academic research and the pharmaceutical industry. The new company is being established with the support of Germany's Federal Ministry of Education & Research, the city of Hamburg, pharmaceutical services company Evotec, and Norgenta, an agency that promotes life sciences development in the German states of Hamburg and Schleswig-Holstein. The center has raised nearly $10 million in financing, including $2 million each from Evotec and Hamburg, and aims to be fully operating by mid-2009. The Swiss Federal Institute of Technology and the Vienna-based Institute of Molecular Biotechnology of the Austrian Academy of Sciences have said they intend to participate.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter